Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
8.09
-0.47 (-5.49%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Teladoc Health Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for Teladoc Health stock have an average target of 11.26, with a low estimate of 8.00 and a high estimate of 17. The average target predicts an increase of 39.18% from the current stock price of 8.09.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Teladoc Health stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
Buy | 5 | 5 | 5 | 5 | 5 | 5 |
Hold | 13 | 13 | 13 | 13 | 11 | 11 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 19 | 20 | 20 | 20 | 18 | 18 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Goldman Sachs | Goldman Sachs | Strong Buy Maintains $16 → $13 | Strong Buy | Maintains | $16 → $13 | +60.69% | Mar 3, 2025 |
Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 27, 2025 |
Piper Sandler | Piper Sandler | Buy Maintains $13 → $12 | Buy | Maintains | $13 → $12 | +48.33% | Feb 27, 2025 |
Goldman Sachs | Goldman Sachs | Strong Buy Maintains $14 → $16 | Strong Buy | Maintains | $14 → $16 | +97.78% | Feb 18, 2025 |
B of A Securities | B of A Securities | Hold Maintains $12 → $14 | Hold | Maintains | $12 → $14 | +66.87% | Feb 12, 2025 |
Financial Forecast
Revenue This Year
2.57B
from 2.57B
Decreased by -0.14%
Revenue Next Year
2.60B
from 2.57B
Increased by 1.48%
EPS This Year
-0.88
from -5.87
EPS Next Year
-0.89
from -0.88
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 2.7B | 2.7B | 2.8B | ||
Avg | 2.6B | 2.6B | 2.7B | ||
Low | 2.4B | 2.4B | 2.4B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.1% | 6.8% | 8.3% | ||
Avg | -0.1% | 1.5% | 2.2% | ||
Low | -5.3% | -6.3% | -8.5% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | -0.22 | -0.08 | -0.91 | |
Avg | -0.88 | -0.89 | -0.89 | |
Low | -1.30 | -1.24 | -0.85 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | - | - | - | |
Avg | - | - | - | |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.